Macrocycle molecule-based cryoprotectants for ice recrystallization inhibition and cell cryopreservation.
J Mater Chem B
; 10(36): 6922-6927, 2022 09 21.
Article
en En
| MEDLINE
| ID: mdl-35979758
ABSTRACT
Cyclodextrin-based cryoprotectants were developed. α-TMCD, which can be easily put into large-scale production, showed enhanced cell viabilities of 19.97 ± 0.78%, 13.93 ± 4.46% and 19.10 ± 0.95% against GES-1, hucMSCs and A549 cells. Moreover, the viable cells observed by light microscope imaging showed that the enhanced hucMSC cell number percentage of α-TMCD was 103.2%. An α-TMCD-DMSO-based CPA exhibited an enhanced cryoprotective effect by a mechanism of DMSO-enhanced cell penetrating effect and α-TMCD-DMSO synergistically enhanced IMA ability. α-TMCD exhibited potential for the discovery of macrocycle-molecule-based cryoprotectants.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Crioprotectores
/
Ciclodextrinas
Idioma:
En
Revista:
J Mater Chem B
Año:
2022
Tipo del documento:
Article